Gotowa bibliografia na temat „Psychotic disease”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Psychotic disease”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Psychotic disease"
Brown, Kayla, Laura Corlin, Maureen Dubreuil, Tien Tran, Hannah Brown i Christina Borba. "M87. PREVALENCE OF AUTOIMMUNE DISEASES IN INDIVIDUALS WITH PRIMARY PSYCHOTIC DISORDERS AT BOSTON MEDICAL CENTER". Schizophrenia Bulletin 46, Supplement_1 (kwiecień 2020): S167—S168. http://dx.doi.org/10.1093/schbul/sbaa030.399.
Pełny tekst źródłaFeinstein, Anthony, George Du Boulay i Maria A. Ron. "Psychotic Illness in Multiple Sclerosis". British Journal of Psychiatry 161, nr 5 (listopad 1992): 680–85. http://dx.doi.org/10.1192/bjp.161.5.680.
Pełny tekst źródłaConnors, Michael H., Armando Teixeira-Pinto i Clement T. Loy. "Psychosis and longitudinal outcomes in Huntington disease: the COHORT Study". Journal of Neurology, Neurosurgery & Psychiatry 91, nr 1 (13.10.2019): 15–20. http://dx.doi.org/10.1136/jnnp-2019-320646.
Pełny tekst źródłaFeinstein, Anthony, i Maria A. Ron. "Psychosis associated with demonstrable brain disease". Psychological Medicine 20, nr 4 (listopad 1990): 793–803. http://dx.doi.org/10.1017/s0033291700036485.
Pełny tekst źródłaFontaine, A., i G. Radu. "New Insights in the Pharmacotherapy of Psychosis: The Example of Parkinson's Disease Psychosis". European Psychiatry 41, S1 (kwiecień 2017): S650. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1083.
Pełny tekst źródłaHernández Sánchez, J. M., M. Á. Canseco Navarro, M. Machado Vera, C. Garay Bravo i D. Peña Serrano. "Late Onset Psychosis. Review". European Psychiatry 33, S1 (marzec 2016): S530. http://dx.doi.org/10.1016/j.eurpsy.2016.01.1962.
Pełny tekst źródłaFriedman, Joseph H. "Atypical Antipsychotic Drugs in the Treatment of Parkinson’s Disease". Journal of Pharmacy Practice 24, nr 6 (17.11.2011): 534–40. http://dx.doi.org/10.1177/0897190011426556.
Pełny tekst źródłaMellers, John D. C., Niall P. Quinn i Maria A. Ron. "Psychotic and Depressive Symptoms in Parkinson's Disease a Study of the Growth Hormone Response to Apomorphine". British Journal of Psychiatry 167, nr 4 (październik 1995): 522–26. http://dx.doi.org/10.1192/bjp.167.4.522.
Pełny tekst źródłaFerreira, M. D. C., S. Varanda, G. Carneiro, B. Santos i Á. Machado. "Parkinson disease psychosis – A case report". European Psychiatry 33, S1 (marzec 2016): S147. http://dx.doi.org/10.1016/j.eurpsy.2016.01.258.
Pełny tekst źródłaBarrett, Matthew J., Jamie C. Blair, Scott A. Sperling, Mark E. Smolkin i T. Jason Druzgal. "Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease". Neurology 90, nr 18 (4.04.2018): e1618-e1626. http://dx.doi.org/10.1212/wnl.0000000000005421.
Pełny tekst źródłaRozprawy doktorskie na temat "Psychotic disease"
Gardin, Tova. "Hippocampal Subfield Alterations Across the Psychotic Disease Spectrum". Thesis, Harvard University, 2017. http://nrs.harvard.edu/urn-3:HUL.InstRepos:32676134.
Pełny tekst źródłaVenneri, Annalena. "A study of psychotic symptoms in Alzheimer's disease : a cognitive and neuroimaging approach". Thesis, University of Aberdeen, 1999. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU116371.
Pełny tekst źródłaClark-Papasavas, Chloe Melissa. "Characterising the neuropsychological profile of psychotic symptoms in Alzheimer's disease and imaging D2/3 receptor occupancy during treatment". Thesis, King's College London (University of London), 2014. https://kclpure.kcl.ac.uk/portal/en/theses/characterising-the-neuropsychological-profile-of-psychotic-symptoms-in-alzheimers-disease-and-imaging-d23-receptor-occupancy-during-treatment(e96bd2b4-7a12-4f4a-923a-637d857bbc2d).html.
Pełny tekst źródłaSvensk, Ludvig, i Johanna Jakobson. "Metabolt syndrom vid psykos : en litteraturstudie om åtgärder mot metabolt syndrom vid psykossjukdom". Thesis, Linköpings universitet, Institutionen för medicin och hälsa, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-144843.
Pełny tekst źródłaBackground: Patient with psychosis often suffer from somatic illness that is expressed as metabolic syndrome. Bad living habits such as bad diet, inactivity, drugs etcetera is factors that contribute to the development of metabolic syndrome. Also, the necessary drug treatment is important for the development of metabolic syndrome. These factors sets the patient group in a risk to die up to 25 years earlier than the average population. Aim: The purpose of the study was to highlight preventive and mitigating nursing interventions against metabolic syndrome in people treated for psychiatric diseases. Method: This study was designed and implemented as a general literature study with a systematic approach. The database research was performed in Cinahl, Pubmed, Scopus, Psycinfo and Psycarticle. The articles was quality-reviewed by Linköpings University’s review-templates and was quality assessed by the authors quality requirement. Result: The result formed three categories; Lifestyles, Social support and Prevention, which depend on each other. Patients' living habits are the main finding for relieving and preventing metabolic syndrome, but in order to be able to implement lifestyle interventions in patients with psychosis, social support and information are needed. These factors also form the basis for preventive work to prevent metabolic syndrome before it develops. Conclusion: In summary, it can be said that the preventative and alleviate measures against metabolic syndrome for people treated for psychiatric disease are to support and encourage the patient to a healthier lifestyle, including increased physical activity and improved diet. It is also the duty of the nurse to personalize care and create a person-centered care tailored to the individual's abilities and needs. Keywords: Psychotic Disease, Metabolic Syndrome, Nursing, Nurse.
McCurdy, Richard D., i n/a. "Investigations of Olfactory Mucosa to Test the Neurodevelopmental Nature of Psychoses". Griffith University. School of Biomolecular and Biomedical Science, 2005. http://www4.gu.edu.au:8080/adt-root/public/adt-QGU20051121.133824.
Pełny tekst źródłaMcCurdy, Richard D. "Investigations of Olfactory Mucosa to Test the Neurodevelopmental Nature of Psychoses". Thesis, Griffith University, 2005. http://hdl.handle.net/10072/366460.
Pełny tekst źródłaThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Biomolecular and Biomedical Sciences
Full Text
Dickson, Marguerite Mulryan. "Genetic and psychiatric treatment related risk factors for type 2 diabetes in schizophrenia and schizoaffective disorder patients". Thesis, Birmingham, Ala. : University of Alabama at Birmingham, 2008. https://www.mhsl.uab.edu/dt/2009r/dickson.pdf.
Pełny tekst źródłaEriksson, Tobias. "Stödet jag behöver : Vad patienter med psykossjukdom i psykiatrisk öppenvård önskar för stöd av sjuksköterskan i sin återhämtning". Thesis, Mälardalens högskola, Akademin för hälsa, vård och välfärd, 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-39246.
Pełny tekst źródłaBakgrund: Det finns tidigare forskning inom området återhämtning och ur ett patientperspektiv. Det är däremot relativt outforskat om fokus riktas mot gruppen psykossjuka och i en kontext av vad de önskar för stöd av just sjuksköterskan inom ramen för den öppna psykiatrin. Syfte: Att beskriva vad patienter med psykossjukdom i den psykiatriska öppenvården önskar för stöd av sjuksköterskan i sin återhämtning. Metod: Studie bygger på fem intervjuade patienter som har kontakt med ett psykiatriskt öppenvårdsteam specialiserat på psykossjukdomar. Studien genomfördes med en induktiv ansats. Insamlade data analyserades utifrån kvalitativ innehållsanalys. Resultat: Det framkommer att patienterna uttrycker en önskan om att sjuksköterskan ger stöd inom fyra huvudområden; att ha fokus på det friska, att få stöd med sina problem, att få berätta för någon som vill lyssna och att få tid att lära känna sjuksköterskan är grunden till en trygg och god relation. Slutsatser: Resultatet svarar på studiens syfte, utifrån resultatet i förhållande till tidigare forskning kan också slutsatsen dras att det är skillnad i vilket stöd som efterfrågas mellan gruppen ”svårt psykiskt sjuka”, som bakgrunden i huvudsak utgörs av, mot gruppen av psykossjuka personer.
Benjamin, Boben. "Metabolic syndrome and psychosis in Alzheimer's disease". Thesis, University of Manchester, 2014. https://www.research.manchester.ac.uk/portal/en/theses/metabolic-syndrome-and-psychosis-in-alzheimers-disease(eedebc61-9cbb-4d8d-9e60-a025f054278a).html.
Pełny tekst źródłaBaum, Matthew L. "Ethical issues in the bioprediction of brain-based disorder". Thesis, University of Oxford, 2013. http://ora.ox.ac.uk/objects/uuid:9978211b-5b61-4dba-bbba-157239664b2c.
Pełny tekst źródłaKsiążki na temat "Psychotic disease"
Mania and depression: A classification of syndrome and disease. Baltimore: Johns Hopkins University Press, 1991.
Znajdź pełny tekst źródłaVulnerability to psychosis: From neurosciences to psychopathology. Hove, East Sussex: Psychology Press, 2012.
Znajdź pełny tekst źródłaImpasse and interpretation: Therapeutic and anti-therapeutic factors in the psychoanalytic treatment of psychotic, borderline and neurotic patients. London: Routledge, 1990.
Znajdź pełny tekst źródłaRosenfeld, Herbert A. Impasse and interpretation: Therapeutic and anti-therapeutic factors in the psychoanalytic treatment of psychotic, borderline and neurotic patients. London: Tavistock, 1987.
Znajdź pełny tekst źródłaMetzl, Jonathan. The protest psychosis: How schizophrenia became a black disease. Boston: Beacon Press, 2010.
Znajdź pełny tekst źródła1961-, Fujii Daryl, i Ahmed Iqbal 1951-, red. The spectrum of psychotic disorders: Neurobiology, etiology, and pathogenesis. Cambridge, UK: Cambridge University Press, 2007.
Znajdź pełny tekst źródłaTesla, Paul Gabriel. Crime and mental disease in the hand: A proven guide for the identification and pre-identification of criminality, psychosis, and mental defectiveness. Lakeland, FL: Osiris Press, 1991.
Znajdź pełny tekst źródłaThomas, Jobe, Gaviria Moises i Kovilparambil Antony, red. Clinical neuropsychiatry. Malden, Mass., USA: Blackwell Science, 1997.
Znajdź pełny tekst źródłaB, Joseph Anthony, i Young Robert R. 1934-, red. Movement disorders in neurology and neuropsychiatry. Wyd. 2. Malden, MA: Blackwell Science, 1999.
Znajdź pełny tekst źródłaB, Joseph Anthony, i Young Robert R. 1934-, red. Movement disorders in neurology and neuropsychiatry. Boston: Blackwell Scientific Publications, 1992.
Znajdź pełny tekst źródłaCzęści książek na temat "Psychotic disease"
Carpenter, W. T., R. W. Buchanan i B. Kirkpatrick. "Schizophrenia: Disease Entity, Disease Entities, or Domains of Psychopathology". W Psychotic Continuum, 137–49. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-79485-8_11.
Pełny tekst źródłaCrow, T. J. "Psychotic Continuum or Disease Entities? The Critical Impact of Nosology on the Problem of Aetiology". W Psychotic Continuum, 151–63. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-79485-8_12.
Pełny tekst źródłaHaggarty, Stephen J., Karun Singh, Roy H. Perlis i Rakesh Karmacharya. "Wnt Signaling in Mood and Psychotic Disorders". W Wnt Signaling in Development and Disease, 379–91. Hoboken, NJ, USA: John Wiley & Sons, Inc, 2014. http://dx.doi.org/10.1002/9781118444122.ch29.
Pełny tekst źródłaAziz, Md Abdul, Tahmina Akter, Md Abdul Barek i Mohammad Safiqul Islam. "Genetic Basis of Psychotic Illnesses: A Comprehensive Overview". W Autism Spectrum Disorder and Alzheimer's Disease, 153–64. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-4558-7_9.
Pełny tekst źródłaOnofrj, Marco, Astrid Thomas, Laura Bonanni, Massimo di Giannantonio, Francesco Gambi i Gianna Sepede. "Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies Evidence Underlying Psychotic Traits". W Psychiatry of Parkinson's Disease, 125–32. Basel: KARGER, 2012. http://dx.doi.org/10.1159/000331658.
Pełny tekst źródłaFulford, K. William M. "Thought Insertion and Insight: Disease and Illness Paradigms of Psychotic Disorder". W Phenomenology, Language & Schizophrenia, 355–71. New York, NY: Springer New York, 1992. http://dx.doi.org/10.1007/978-1-4613-9329-0_23.
Pełny tekst źródłaDas, Partha Pratim, S. K. Batin Rahaman, Adil Shaharyar, Rudranil Bhowmik, Avishek Mandal i Sanmoy Karmakar. "Plant-Derived Anti-Psychotic Drugs: An Insight into Receptor and Phytoconstituent Interaction". W Bioactive-Loaded Nanomedicine for the Management of Health and Disease, 111–37. New York: Apple Academic Press, 2022. http://dx.doi.org/10.1201/9781003277101-8.
Pełny tekst źródłaTheodoridou, A., i W. Rössler. "Disease Burden and Disability-Adjusted Life Years Due to Schizophrenia and Psychotic Disorders". W Handbook of Disease Burdens and Quality of Life Measures, 1493–507. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-0-387-78665-0_87.
Pełny tekst źródłaToriizuka, Kazuo, Yumiko Hori, Motonori Fukumura, Susumu Isoda, Yasuaki Hirai i Yoshiteru Ida. "Investigation of the anxiolytic effects of Kampo formulation, Kamishoyosan, used for treating menopausal psychotic syndromes in women". W Transmitters and Modulators in Health and Disease, 183–89. Tokyo: Springer Japan, 2009. http://dx.doi.org/10.1007/978-4-431-99039-0_16.
Pełny tekst źródłaMolho, Eric S., i Stewart A. Factor. "Psychosis". W Parkinson’s Disease and Nonmotor Dysfunction, 63–90. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-60761-429-6_5.
Pełny tekst źródłaStreszczenia konferencji na temat "Psychotic disease"
Silva, Thais Ellen de Ramos, Diego Rodrigues Castelhano, Cintia Anchieta i Bruna Kuhn de Freitas Silva. "Benefits of using cannabidiol in the treatment of dyskinesias in patients with Parkinson’s". W XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.301.
Pełny tekst źródłaMiclutia, Ioana Valentina, Laura Damian i Ana Cristina Serban. "SEXUAL FUNCTIONING IN SCHIZOPHRENIC AND BIPOLAR FEMALE PATIENTS". W The European Conference of Psychiatry and Mental Health "Galatia". Archiv Euromedica, 2023. http://dx.doi.org/10.35630/2022/12/psy.ro.13.
Pełny tekst źródłaOscoz Irurozqui, Maitane, Maria Guardiola-Ripoll, Carmen Almodóvar-Payá, Amalia Guerrero-Pedraza, Edith Pomarol-Clotet i Mar Fatjó. "CNR2 GENE AND CANNABIS USE INTERPLAY MODULATES MANIPULATIVE ABILITIES IN FIRST-EPISODE OF PSYCHOSIS". W 23° Congreso de la Sociedad Española de Patología Dual (SEPD) 2021. SEPD, 2021. http://dx.doi.org/10.17579/sepd2021o003.
Pełny tekst źródłaPâslaru, Ana Maria, Ana Maria Fătu, Alexandru Nechifor, Laura Florentina Rebegea, Diana Bulgaru Iliescu i Anamaria Ciubara. "PSYCHO-ONCOLOGY. CASE PRESENTATION". W The European Conference of Psychiatry and Mental Health "Galatia". Archiv Euromedica, 2023. http://dx.doi.org/10.35630/2022/12/psy.ro.35.
Pełny tekst źródłaBarbosa, P., M. França, I. Almeida, F. Farinha i C. Vasconcelos. "SAT0130 Toxic psychosis related with hydroxychloroquine". W Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.563.
Pełny tekst źródłaFernandes, Lucca Ferdinando Queiroz, Raiana Carol de Medeiros Dantas, Maria Clara Medeiros Araújo i Lucas de Oliveira Araújo Andrade. "Non-motor clinical manifestations of Parkinson’s disease and its relevance in early diagnosis". W XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.100.
Pełny tekst źródłaSalemi, S., A. Aeschlimann, B. Michel, R. Gay, S. Gay i H. Sprott. "SAT0126 Expression of opioid receptors in chronic pain patients with fibromyalgia, osteoarthritis, psychosis, rheumatoid arthritis and healthy controls". W Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.559.
Pełny tekst źródłaLi, Xiao-Yan, i Zhi-Ying Wu. "F25 The clinical, imaging and biological features of psychosis in Han Chinese patients with huntington’s disease". W EHDN Abstracts 2021. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/jnnp-2021-ehdn.68.
Pełny tekst źródłaInnocencio, Giovanna de Camargo, Juliana de Souza Rosa, Patrick de Abreu Cunha Lopes, Paulo Roberto Hernandes Júnior i Jhoney Francieis Feitosa. "Clinical overview and therapeutic management of the cognitive and behavorial aspects of Huntington’s disease". W XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.177.
Pełny tekst źródłaChirita, Anca Livia, Mihaela Popescu, Veronica Calborean, Victor Gheorman i Ion Udristoiu. "PSYCHIATRIC DISORDERS ASSOCIATED WITH ENDOCRINE DYSFUNCTIONS". W The European Conference of Psychiatry and Mental Health "Galatia". Archiv Euromedica, 2023. http://dx.doi.org/10.35630/2022/12/psy.ro.25.
Pełny tekst źródła